of all known HIV-1 isolates. Additional work will be required to understand the contribution of chemokine receptor binding to entry-related conformational changes.
Conformational Changes in gp41
Despite uncertainties about how chemokine receptor binding promotes the membrane fusion process, it is likely that gp41 undergoes conformational changes from an as-yet-undefined prefusogenic state to one that mediates membrane fusion (Figure 1, middle groove. At one end of this groove is a 400 Å 3 pocket that the C34 peptides act in a dominant-negative fashthat accommodates three hydrophobic C34 residues, ion, packing into the grooves of the N36 coiled coil and isoleucine 635, tryptophan 631, and tryptophan 628 (Figpreventing the natural C34 region on gp41 from doing ure 2). In addition, one of the N36 pocket-lining residues, so (Figure 1, middle panel) . This model of inhibition is lysine 574, forms a salt bridge with aspartic acid 632 of supported by the correlation between the ability of muthe C34 helix. Some C34-like peptides that lack these tant C34 peptides to bind the N36 coiled coils and viruspocket-contacting residues still exhibit reasonably poinhibiting activity Table 1 ). Although the currently identified nonnatural elements appear to interact with the N36 used to screen a phage library expressing peptides of ten random residues flanked by either cysteines or serpocket less efficiently than the natural C34 residues (Ferrer et al., 1999) , it can be anticipated that future ines. The selected phage exhibited consensus peptide detailed structures of these inhibitors complexed with N36 trimers will assist the development of more potent pocket-filling molecules.
Future Considerations
As inhibitors of the gp41 conformational change undergo more extensive clinical testing, we can anticipate that, as for all other antiretroviral agents studied to date, virus variants exhibiting some degree of drug resistance will emerge. Viruses selected in tissue culture systems to be resistant to C34 peptides exhibit changes in the hydrophobic groove of the N36 trimer, not in the pocket (Rimsky et al., 1998) . Indeed, the pocket-lining residues are well conserved among primate immunodeficiency viruses, providing hope that any resistant virus variants will be significantly reduced in fitness. However, the viral capacity for variation in this structure may only be revealed once the selective pressure associated with pocket-specific inhibitors is applied. The potential coevolution of complementary N36 and C34 gp41 regions creates a greater number of opportunities for the development of resistance. The wealth of new knowledge about gp41 structure and function, and about HIV-1 entry in general, should assist efforts to address these challenges. Therapeutic additions to our current armamentarium of antiretroviral agents would be most welcome.
